Adderall supply woes continue as the FDA confirms shortage of immediate release capsules

While it’s been only a few days since more manufacturers of generic Adderall capsules announced upcoming shortages, the FDA is also raising concerns on the issue.

The regulator announced that there was a shortage of the immediate release version of the generic, which treats ADHD and narcolepsy.